90
Views
7
CrossRef citations to date
0
Altmetric
Expert Opinion

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

, , , , &
Pages 85-93 | Published online: 09 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Guangxiu Deng & Lan Jin. (2017) The effects of vasoactive intestinal peptide in neurodegenerative disorders. Neurological Research 39:1, pages 65-72.
Read now
A. Arya, R. Meena, N. K. Sethy, M. Das, M. Sharma & K. Bhargava. (2015) NAP (davunetide) protects primary hippocampus culture by modulating expression profile of antioxidant genes during limiting oxygen conditions. Free Radical Research 49:4, pages 440-452.
Read now
Simona Spaccavento, Marina Del Prete, Angela Craca & Anna Loverre. (2014) A case of atypical progressive supranuclear palsy. Clinical Interventions in Aging 9, pages 31-39.
Read now
Bruce H Morimoto, Anthony W Fox, Alistair J Stewart & Michael Gold. (2013) Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases. Expert Review of Clinical Pharmacology 6:5, pages 483-502.
Read now

Articles from other publishers (3)

Oxana Kapitansky, Eliezer Giladi, Iman Jaljuli, Stefan Bereswill, Markus M. Heimesaat & Illana Gozes. (2020) Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond. Journal of Neural Transmission 127:2, pages 251-263.
Crossref
Eri Saijo, Bernardino Ghetti, Gianluigi Zanusso, Adrian Oblak, Jennifer L. Furman, Marc I. Diamond, Allison Kraus & Byron Caughey. (2017) Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid. Acta Neuropathologica 133:5, pages 751-765.
Crossref
Jonathan Graff-Radford & Kejal Kantarci. 2016. Magnetic Resonance Spectroscopy of Degenerative Brain Diseases. Magnetic Resonance Spectroscopy of Degenerative Brain Diseases 55 70 .